(Q35180101)
Statements
1 reference
Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies (English)
1 reference
Hagop Kantarjian
1 reference
Arthur E Frankel
1 reference
Daniel A Vallera
1 reference
Veronika Bachanova
1 reference
Qing Cao
1 reference
Dixie Lewis
1 reference
Bartosz Grzywacz
1 reference
Michael R Verneris
1 reference
Celalettin Ustun
1 reference
Aleksandr Lazaryan
1 reference
Brian McClune
1 reference
Erica D Warlick
1 reference
Daniel J Weisdorf
1 reference
Jeffrey S Miller
1 reference
1 March 2015
1 reference
1 reference
21
1 reference
6
1 reference
1267-1272
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference